HCPCS codes released for COVID-19 prophylaxis after FDA approval
The Food and Drug Administration (FDA) recently announced an emergency use authorization for Pemgarda, a pre-exposure prophylaxis for COVID-19, leading to the release of HCPCS Level II codes for the drug and its administration.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.